Type of Study:

Observational

Study Design:

Time Perspective: Prospective

Outcome Measure:

Evaluate if study product has been completely degraded in the breast 4 years post treatment in study 31GB0607, using MRI

Outcome Time Frame:

4 years

Safety Issue:

Yes

Principal Investigator

Per Hedén, M.D.

Investigator Role:

Principal Investigator

Investigator Affiliation:

Akademikliniken, Stockholm, Sweden

Authority:

Sweden: Regional Ethical Review Board

Study ID:

31GB1103

NCT ID:

NCT01609400

Start Date:

December 2011

Completion Date:

May 2014

Related Keywords:

• Breast Enhancement